Rilonacept (IL-1 Trap) Demonstrates Rapid Reduction Of Clinical Symptoms In Patients With Cryopyrin-Associated Periodic Syndromes (CAPS) In A Placebo-Controlled Trial von Cartwright, R, Throne, M, Nadler, D, Mahony, M, Weinstein, S.P, Mellis, S.J

Volltext

Durability of Response to Rilonacept (IL-1 Trap) in a Phase 3 Study of Patients with Cryopyrin-Associated Periodic Syndromes (CAPS): Familial Cold Autoinflammatory Syndrome (FCAS)... von Hoffman, H.M, Amar, N.J, Cartwright, R.C, Kivitz, A.J, Belomestnov, P, Mellis, S.J, Weinstein, S.P

Volltext

The First Placebo-Controlled Trial in Cryopyrin-Associated Periodic Syndromes (CAPS): IL-1 Trap (rilonacept) Markedly Reduces Clinical and Laboratory Abnormalities in Patients with... von Hoffman, H.M, Weinstein, S.P, Amar, N.J, Throne, M.L, Boling, E.P, Grimes, I.M, Belomestnov, P, Stein, D.R, Vicary, C, Mellis, S.J

Volltext

Field assessment of crusting on a tilled sandy clay loam von Mellis, D.A., Bruneau, P.M.C., Twomlow, S.J., Morgan, R.P.C.

Volltext

Cystic fibrosis: onset of symptoms, delay in clinical diagnosis, and the implications for newborn screening von Wilcken, Bridget, Mellis, C.M., Towns, S.J., Brown, A.R.D.

Volltext